These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37685683)

  • 1. Plasma Cell-Free DNA and Caspase-3 Levels in Patients with Chronic Kidney Disease.
    Clementi A; Virzì GM; Manani SM; de Cal M; Battaglia GG; Ronco C; Zanella M
    J Clin Med; 2023 Aug; 12(17):. PubMed ID: 37685683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Cell-Free Plasma DNA in Patients with Cardiorenal Syndrome Type 1.
    Virzì GM; Clementi A; Milan Manani S; Castellani C; Battaglia GG; Angelini A; Vescovo G; Ronco C
    Cardiorenal Med; 2021; 11(5-6):218-225. PubMed ID: 34518452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of chronic kidney disease and short-term treatment with rosiglitazone on plasma cell-free DNA levels.
    McGuire AL; Urosevic N; Chan DT; Dogra G; Inglis TJ; Chakera A
    PPAR Res; 2014; 2014():643189. PubMed ID: 25371664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EBV load is associated with cfDNA fragmentation and renal damage in SLE patients.
    Truszewska A; Wirkowska A; Gala K; Truszewski P; Krzemień-Ojak Ł; Mucha K; Pączek L; Foroncewicz B
    Lupus; 2021 Jul; 30(8):1214-1225. PubMed ID: 33866897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Cell-Free Plasma DNA in Critically Ill Patients with Sepsis.
    Clementi A; Virzì GM; Brocca A; Pastori S; de Cal M; Marcante S; Granata A; Ronco C
    Blood Purif; 2016; 41(1-3):34-40. PubMed ID: 26960212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-free plasma DNA during peritoneal dialysis and hemodialysis and in patients with chronic kidney disease.
    Korabecna M; Opatrna S; Wirth J; Rulcova K; Eiselt J; Sefrna F; Horinek A
    Ann N Y Acad Sci; 2008 Aug; 1137():296-301. PubMed ID: 18837963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of Circulating Cell-Free DNA and Positron Emission Tomography to Distinguish Non-Small Cell Lung Cancer from Tuberculosis.
    Zheng W; Quan B; Gao G; Zhang P; Huang L
    Lab Med; 2023 Mar; 54(2):130-141. PubMed ID: 36106407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the source and prognostic utility of cfDNA in trauma and sepsis.
    Jackson Chornenki NL; Coke R; Kwong AC; Dwivedi DJ; Xu MK; McDonald E; Marshall JC; Fox-Robichaud AE; Charbonney E; Liaw PC
    Intensive Care Med Exp; 2019 May; 7(1):29. PubMed ID: 31119471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-free DNA levels in plasma of patients with non-small-cell lung cancer and inflammatory lung disease.
    Szpechcinski A; Chorostowska-Wynimko J; Struniawski R; Kupis W; Rudzinski P; Langfort R; Puscinska E; Bielen P; Sliwinski P; Orlowski T
    Br J Cancer; 2015 Jul; 113(3):476-83. PubMed ID: 26125447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-free DNA as a marker for the outcome of end-stage renal disease patients on haemodialysis.
    Coimbra S; Rocha S; Nascimento H; Valente MJ; Catarino C; Rocha-Pereira P; Sameiro-Faria M; Oliveira JG; Madureira J; Fernandes JC; Miranda V; Belo L; Bronze-da-Rocha E; Santos-Silva A
    Clin Kidney J; 2021 May; 14(5):1371-1378. PubMed ID: 33959266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating cell-free DNA: an up-coming molecular marker in exercise physiology.
    Breitbach S; Tug S; Simon P
    Sports Med; 2012 Jul; 42(7):565-86. PubMed ID: 22694348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythrocyte caspase-3 levels in children with chronic kidney disease.
    Polak-Jonkisz D; Purzyc L; Szcepańska M; Makulska I
    Clin Biochem; 2013 Feb; 46(3):219-24. PubMed ID: 23103707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ribosomal repeat in the cell free DNA as a marker for cell death].
    Veĭko NN; Bulycheva NV; Roginko OA; Veĭko RV; Ershova ES; Kozdoba OA; Kuz'min VA; Vinogradov AM; Iudin AA; Speranskiĭ AI
    Biomed Khim; 2008; 54(1):78-93. PubMed ID: 18421913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RIPK3-Mediated Necroptosis and Apoptosis Contributes to Renal Tubular Cell Progressive Loss and Chronic Kidney Disease Progression in Rats.
    Zhu Y; Cui H; Xia Y; Gan H
    PLoS One; 2016; 11(6):e0156729. PubMed ID: 27281190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum cell-free DNA and progression of diabetic kidney disease: a prospective study.
    Li X; Hu R; Luo T; Peng C; Gong L; Hu J; Yang S; Li Q
    BMJ Open Diabetes Res Care; 2020 Mar; 8(1):. PubMed ID: 32152147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can salivary creatinine and urea levels be used to diagnose chronic kidney disease in children as accurately as serum creatinine and urea levels? A case-control study.
    Renda R
    Ren Fail; 2017 Nov; 39(1):452-457. PubMed ID: 28372505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma cell-free DNA levels in children on peritoneal dialysis.
    Ozkaya O; Bek K; Bedir A; Açikgöz Y; Ozdemir T
    Nephron Clin Pract; 2009; 113(4):c258-61. PubMed ID: 19684410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating secreted frizzled-related protein 5 and chronic kidney disease in patients with acute ST-segment elevation myocardial infarction.
    Wang CP; Yu TH; Wu CC; Hung WC; Hsu CC; Tsai IT; Tang WH; Chung FM; Houng JY; Lee YJ; Lu YC
    Cytokine; 2018 Oct; 110():367-373. PubMed ID: 29807686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between urinary kidney injury molecule-1 and blood bone metabolism markers in patients with chronic kidney disease
.
    Yin C; Cheng C; Wang J; Zhang L; Purrunsing Y; Yang G; Zeng M; Huang H; Ren W; Ye Y; Ma H; Xing C; Wang N
    Clin Nephrol; 2020 Feb; 93(2):65-76. PubMed ID: 31793871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High levels of cell-free DNA accurately predict late acute kidney injury in patients after cardiac surgery.
    Merkle J; Daka A; Deppe AC; Wahlers T; Paunel-Görgülü A
    PLoS One; 2019; 14(6):e0218548. PubMed ID: 31211810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.